Q4 2025 Management View Emmanuel Lakios, President and CEO, stated that the company has "initiated a transformation strategy during the fourth quarter designed to significantly reduce fixed operating ...

​Biotechnology company Lipella Pharmaceuticals Inc. files for Chapter 11 bankruptcy months after facing Nasdaq delisting.

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

OFAC extended the deadline for buyers to negotiate Lukoil's $22B foreign assets to May 1, with Carlyle, Chevron, and rival ...

ReShape Lifesciences® announced a partial adjournment of their Special Meeting of Stockholders regarding Proposals 2 and 3, which entail the sale of the company's assets to Ninjour Health ...

Ryan M. Lance, CEO, announced "another strong execution quarter, once again exceeding the top end of our production guidance range," and confirmed the midpoint of full year production guidance remains ...

The owner is retiring with pride, knowing the business was built on quality, precision, and reliability. This sale allows the next generation to benefit from decades of investment and craftsmanship.” ...

Activist-led turnaround has refocused Amplify on core assets, improved governance, and aligned management incentives with shareholder returns. Strategic asset sales nearly match current enterprise ...

Abeona Therapeutics is a commercial-stage biotech focused on developing cell and gene therapies for severe and rare diseases. Its portfolio centers around ZEVASKYN, an autologous cell-based gene ...